Effect of statin on MS progression not related to cholesterol reduction
A previously demonstrated effect of simvastatin in delaying progression of an advanced form of multiple sclerosis is not related to its effect on cholesterol levels, a study published in PNAS has shown.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Cholesterol | Drugs & Pharmacology | Multiple Sclerosis | Simvastatin | Statin Therapy | Study | Zocor